<DOC>
	<DOCNO>NCT00000957</DOCNO>
	<brief_summary>To evaluate safety immune response vaccinia-derived HIV-1 recombinant envelope glycoprotein ( gp160 ) use accelerate dosage schedule ; evaluate duration antibody response relationship dose frequency inoculation . Although recent advance make antiviral therapy AIDS , currently cure AIDS . It likely ultimate control disease depend development safe effective vaccine HIV .</brief_summary>
	<brief_title>A Phase I Multicenter Clinical Trial Evaluate Safety Immunogenicity Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein ( gp160 ) Human Immunodeficiency Virus : Evaluation Accelerated Schedules</brief_title>
	<detailed_description>Although recent advance make antiviral therapy AIDS , currently cure AIDS . It likely ultimate control disease depend development safe effective vaccine HIV . Thirty healthy adult volunteer without identifiable high-risk behavior HIV-1 randomly assign receive vaccination gp160 ( 50 mcg ) accord one follow schedule : Group 1 receives vaccine day 0 , 28 , 56 , 140 placebo day 84 112 ; Group 2 receives vaccine day 0 , 28 , 56 , 84 , 112 placebo day 140 . Subjects follow 1 year last injection . Per 05/13/94 amendment , 10 subject St. Louis University site receive additional boost 18-24 month last injection .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Vaccinia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Inclusion Criteria Patients must : Normal , healthy , HIVnegative adult fully comprehend purpose detail study . Available 1 year followup . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : They sexual partner identifiable highrisk behavior HIV infection . Positive syphilis serology ( e.g. , VDRL ) . Positive circulate hepatitis B antigen . Patients follow prior condition exclude : History positive PPD ( tuberculin test ) . History immunodeficiency chronic illness . Evidence depression treatment psychiatric problem past year . Prior Medication : Excluded : Immunosuppressive medication . Prior Treatment : Excluded : Blood transfusion cryoprecipitates within past 6 month . Risk Behavior : Excluded : Highrisk behavior HIV infection . History intravenous drug use . More one sexual partner last 6 month . Syphilis , gonorrhea , sexually transmit disease ( include chlamydia pelvic inflammatory disease ) past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Vaccines , Synthetic</keyword>
	<keyword>Vaccinia Virus</keyword>
	<keyword>Viral Vaccines</keyword>
	<keyword>HIV-1</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>HIV Envelope Protein gp160</keyword>
	<keyword>Drug Administration Schedule</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>HIV Preventive Vaccine</keyword>
</DOC>